Protext is a Biotech Company developing a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies and is a subsidiary of RSAMMD Acquisitions LLC, (The Holding Company) that Is Jointly Owned with Two Principals, Mr Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”)

Through its prior acquisitions, Protext has engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through the use of proprietary live plant extraction technology.